The essential role of G protein-coupled receptor (GPCR) signaling in regulating T cell immunity

References

• Rosenbaum DM, Rasmussen SG, Kobilka BK. The structure and function of G-protein-coupled receptors. Nature 2009;459:356–363.
   PubMed Web of Science ®Google Scholar
• Venkatakrishnan AJ, Deupi X, Lebon G, et al. Molecular signatures of G-protein-coupled receptors. Nature 2017;494:185–194.
   Google Scholar
• Chini B, Parenti M, Poyner DR, Wheatley M. G-protein-coupled receptors: from structural insights to functional mechanisms. Biochem Soc Trans 2013;41:135–136.
   PubMed Web of Science ®Google Scholar
• Heng BC, Aubel D, Fussenegger M. An overview of the diverse roles of G-protein coupled receptors (GPCRs) in the pathophysiology of various human diseases. Biotechnol Adv 2013;31:1676–1694.
   PubMed Web of Science ®Google Scholar
• Williams C, Hill SJ. GPCR signaling: understanding the pathway to successful drug discovery. Methods Mol Biol 2009;552:39–50.
   PubMedGoogle Scholar
• Zhao P, Cladman W, Van Tol HH, Chidiac P. Fine-tuning of GPCR signals by intracellular G protein modulators. Prog Mol Biol Transl Sci 2013;115:421–453.
   PubMed Web of Science ®Google Scholar
• Musnier A, Blanchot B, Reiter E, Crepieux P. GPCR signalling to the translation machinery. Cell Signal 2010;22:707–716.
   PubMed Web of Science ®Google Scholar
• Fujioka M, Omori N. Subtleties in GPCR drug discovery: a medicinal chemistry perspective. Drug Discov Today 2012;17:1133–1138.
   PubMed Web of Science ®Google Scholar
• MacIver NJ, Michalek RD, Rathmell JC. Metabolic regulation of T lymphocytes. Annu Rev Immunol 2013;31:259–283.
   PubMed Web of Science ®Google Scholar
• Goodnow CC. Balancing immunity and tolerance: deleting and tuning lymphocyte repertoires. Proc Natl Acad Sci USA 1996;93:2264–2271.
   PubMed Web of Science ®Google Scholar
• Zhao Q, Wu BL. Ice breaking in GPCR structural biology. Acta Pharmacol Sin 2012;33:324–334.
   PubMed Web of Science ®Google Scholar
• Neves SR, Ram PT, Iyengar R. G protein pathways. Science 2002;296:1636–1639.
   PubMed Web of Science ®Google Scholar
• Jalink K, Moolenaar WH. G protein-coupled receptors: the inside story. Bioessays 2010;32:13–16.
   PubMed Web of Science ®Google Scholar
• McCudden CR, Hains MD, Kimple RJ, et al. G-protein signaling: back to the future. Cell Mol Life Sci 2005;62:551–577.
   PubMed Web of Science ®Google Scholar
• Sugimoto Y, Narumiya S, Ichikawa A. Distribution and function of prostanoid receptors: studies from knockout mice. Prog Lipid Res 2000;39:289–314.
   PubMed Web of Science ®Google Scholar
• Nagamachi M, Sakata D, Kabashima K, et al. Facilitation of Th1-mediated immune response by prostaglandin E receptor EP1. J Exp Med 2007;204:2865–2874.
   PubMed Web of Science ®Google Scholar
• Nataraj C, Thomas DW, Tilley SL, et al. Receptors for prostaglandin E(2) that regulate cellular immune responses in the mouse. J Clin Invest 2001;108:1229–1235.
   PubMed Web of Science ®Google Scholar
• Boniface K, Bak-Jensen KS, Li Y, et al. Prostaglandin E2 regulates Th17 cell differentiation and function through cyclic AMP and EP2/EP4 receptor signaling. J Exp Med 2009;206:535–548.
   PubMed Web of Science ®Google Scholar
• Yao C, Sakata D, Esaki Y, et al. Prostaglandin E2-EP4 signaling promotes immune inflammation through Th1 cell differentiation and Th17 cell expansion. Nat Med 2009;15:633–640.
   PubMed Web of Science ®Google Scholar
• Harrison C. G protein-coupled receptors: insights into chemokine receptors. Nat Rev Drug Discov 2010;9:920.
   PubMed Web of Science ®Google Scholar
• Muller M, Carter S, Hofer MJ, Campbell IL. Review: the chemokine receptor CXCR3 and its ligands CXCL9, CXCL10 and CXCL11 in neuroimmunity-a tale of conflict and conundrum. Neuropathol Appl Neurobiol 2010;36:368–387.
   PubMed Web of Science ®Google Scholar
• Groom JR, Luster AD. CXCR3 in T cell function. Exp Cell Res 2011;317:620–631.
   PubMed Web of Science ®Google Scholar
• Steinmetz OM, Turner JE, Paust HJ, et al. CXCR3 mediates renal Th1 and Th17 immune response in murine lupus nephritis. J Immunol 2009;183:4693–4704.
   PubMed Web of Science ®Google Scholar
• Oo YH, Weston CJ, Lalor PF, et al. Distinct roles for CCR4 and CXCR3 in the recruitment and positioning of regulatory T cells in the inflamed human liver. J Immunol 2010;184:2886–2898.
   PubMed Web of Science ®Google Scholar
• Hoerning A, Koss K, Datta D, et al. Subsets of human CD4(+) regulatory T cells express the peripheral homing receptor CXCR3. Eur J Immunol 2011;41:2291–2302.
   PubMed Web of Science ®Google Scholar
• Kucia M, Jankowski K, Reca R, et al. CXCR4-SDF-1 signalling, locomotion, chemotaxis and adhesion. J Mol Histol 2004;35:233–245.
   PubMed Web of Science ®Google Scholar
• Ottoson NC, Pribila JT, Chan AS, Shimizu Y. Cutting edge: T cell migration regulated by CXCR4 chemokine receptor signaling to ZAP-70 tyrosine kinase. J Immunol 2001;167:1857–1861.
   PubMed Web of Science ®Google Scholar
• Kumar A, Humphreys TD, Kremer KN, et al. CXCR4 physically associates with the T cell receptor to signal in T cells. Immunity 2006;25:213–224.
   PubMed Web of Science ®Google Scholar
• Contento RL, Molon B, Boularan C, et al. CXCR4-CCR5: a couple modulating T cell functions. Proc Natl Acad Sci USA 2008;105:10101–10106.
   PubMed Web of Science ®Google Scholar
• Alkhatib G. The biology of CCR5 and CXCR4. Curr Opin HIV AIDS 2009;4:96–103.
   PubMed Web of Science ®Google Scholar
• Castellino F, Huang AY, Altan-Bonnet G, et al. Chemokines enhance immunity by guiding naive CD8+ T cells to sites of CD4+ T cell-dendritic cell interaction. Nature 2006;440:890–895.
   PubMed Web of Science ®Google Scholar
• Kohlmeier JE, Miller SC, Smith J, et al. The chemokine receptor CCR5 plays a key role in the early memory CD8+ T cell response to respiratory virus infections. Immunity 2008;29:101–113.
   PubMed Web of Science ®Google Scholar
• Gonzalez-Martin A, Gomez L, Lustgarten J, et al. Maximal T cell-mediated antitumor responses rely upon CCR5 expression in both CD4(+) and CD8(+) T cells. Cancer Res 2011;71:5455–5466.
   PubMed Web of Science ®Google Scholar
• O'Sullivan C, Dev KK. The structure and function of the S1P1 receptor. Trends Pharmacol Sci 2013;34:401–412.
   PubMed Web of Science ®Google Scholar
• Jin Y, Knudsen E, Wang L, et al. Sphingosine 1-phosphate is a novel inhibitor of T-cell proliferation. Blood 2003;101:4909–4915.
   PubMed Web of Science ®Google Scholar
• Matloubian M, Lo CG, Cinamon G, et al. Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1. Nature 2004;427:355–360.
   PubMed Web of Science ®Google Scholar
• Svenningsson P, Le Moine C, Fisone G, Fredholm BB. Distribution, biochemistry and function of striatal adenosine A2A receptors. Prog Neurobiol 1999;59:355–396.
   PubMed Web of Science ®Google Scholar
• Himer L, Csoka B, Selmeczy Z, et al. Adenosine A2A receptor activation protects CD4+ T lymphocytes against activation-induced cell death. FASEB J 2010;24:2631–2640.
   PubMed Web of Science ®Google Scholar
• Zarek PE, Huang CT, Lutz ER, et al. A2A receptor signaling promotes peripheral tolerance by inducing T-cell anergy and the generation of adaptive regulatory T cells. Blood 2008;111:251–259.
   PubMed Web of Science ®Google Scholar
• von Kugelgen I, Harden TK. Molecular pharmacology, physiology, and structure of the P2Y receptors. Adv Pharmacol 2011;61:373–415.
   PubMedGoogle Scholar
• Somers GR, Hammet FM, Trute L, et al. Expression of the P2Y6 purinergic receptor in human T cells infiltrating inflammatory bowel disease. Lab Invest 1998;78:1375–1383.
   PubMed Web of Science ®Google Scholar
• Tsukimoto M, Tokunaga A, Harada H, Kojima S. Blockade of murine T cell activation by antagonists of P2Y6 and P2X7 receptors. Biochem Biophys Res Commun 2009;384:512–518.
   PubMed Web of Science ®Google Scholar
• Chung S, Funakoshi T, Civelli O. Orphan GPCR research. Br J Pharmacol 2008;153:S339–S346.
   PubMed Web of Science ®Google Scholar
• Civelli O, Saito Y, Wang Z, et al. Orphan GPCRs and their ligands. Pharmacol Ther 2006;110:525–532.
   PubMed Web of Science ®Google Scholar
• Prossnitz ER, Oprea TI, Sklar LA, Arterburn JB. The ins and outs of GPR30: a transmembrane estrogen receptor. J Steroid Biochem Mol Biol 2008;109:350–353.
   PubMed Web of Science ®Google Scholar
• Maggiolini M, Picard D. The unfolding stories of GPR30, a new membrane-bound estrogen receptor. J Endocrinol 2010;204:105–114.
   PubMed Web of Science ®Google Scholar
• Bodhankar S, Vandenbark AA, Offner H. Oestrogen treatment of experimental autoimmune encephalomyelitis requires 17β-oestradiol-receptor-positive B cells that up-regulate PD-1 on CD4+ Foxp3+ regulatory T cells. Immunology 2012;137:282–293.
   PubMed Web of Science ®Google Scholar
• Wang C, Dehghani B, Magrisso IJ, et al. GPR30 contributes to estrogen-induced thymic atrophy. Mol Endocrinol. 2008;22:636–648.
   PubMed Web of Science ®Google Scholar
• Yates MA, Li Y, Chlebeck PJ, Offner H. GPR30, but not estrogen receptor-alpha, is crucial in the treatment of experimental autoimmune encephalomyelitis by oral ethinyl estradiol. BMC Immunol 2010;11:20.
   PubMed Web of Science ®Google Scholar
• Le LQ, Kabarowski JH, Weng Z, et al. Mice lacking the orphan G protein-coupled receptor G2A develop a late-onset autoimmune syndrome. Immunity 2001;14:561–571.
   PubMed Web of Science ®Google Scholar
• Radu CG, Yang LV, Riedinger M, et al. T cell chemotaxis to lysophosphatidylcholine through the G2A receptor. Proc Natl Acad Sci USA 2004;101:245–250.
   PubMed Web of Science ®Google Scholar
• Peng YM, van de Garde MD, Cheng KF, et al. Specific expression of GPR56 by human cytotoxic lymphocytes. J Leukoc Biol 2011;90:735–740.
   PubMed Web of Science ®Google Scholar
• Magalhaes AC, Dunn H, Ferguson SS. Regulation of GPCR activity, trafficking and localization by GPCR-interacting proteins. Br J Pharmacol 2012;165:1717–1736.
   PubMed Web of Science ®Google Scholar
• De Vries L, Zheng B, Fischer T, et al. The regulator of G protein signaling family. Annu Rev Pharmacol Toxicol 2000;40:235–271.
   PubMed Web of Science ®Google Scholar
• Roman DL, Traynor JR. Regulators of G protein signaling (RGS) proteins as drug targets: modulating G-protein-coupled receptor (GPCR) signal transduction. J Med Chem 2011;54:7433–7440.
   PubMed Web of Science ®Google Scholar
• Gibbons DL, Abeler-Dorner L, Raine T, et al. Cutting edge: regulator of G protein signaling-1 selectively regulates gut T cell trafficking and colitic potential. J Immunol 2011;187:2067–2071.
   PubMed Web of Science ®Google Scholar
• Williams JW, Yau D, Sethakorn N, et al. RGS3 controls T lymphocyte migration in a model of Th2-mediated airway inflammation. Am J Physiol Lung Cell Mol Physiol 2013;305:L693–L701.
   PubMed Web of Science ®Google Scholar
• Shankar SP, Wilson MS, DiVietro JA, et al. RGS16 attenuates pulmonary Th2/Th17 inflammatory responses. J Immunol 2012;188:6347–6356.
   PubMed Web of Science ®Google Scholar
• Moore CA, Milano SK, Benovic JL. Regulation of receptor trafficking by GRKs and arrestins. Annu Rev Physiol 2007;69:451–482.
   PubMed Web of Science ®Google Scholar
• Vroon A, Heijnen CJ, Kavelaars A. GRKs and arrestins: regulators of migration and inflammation. J Leukoc Biol 2006;80:1214–1221.
   PubMed Web of Science ®Google Scholar
• Lombardi MS, Kavelaars A, Schedlowski M, et al. Decreased expression and activity of G-protein-coupled receptor kinases in peripheral blood mononuclear cells of patients with rheumatoid arthritis. FASEB J 1999;13:715–725.
   PubMed Web of Science ®Google Scholar
• Kang DS, Tian X, Benovic JL. Beta-arrestins and G protein-coupled receptor trafficking. Methods Enzymol 2013;521:91–108.
   PubMed Web of Science ®Google Scholar
• Pierce KL, Lefkowitz RJ. Classical and new roles of beta-arrestins in the regulation of G-protein-coupled receptors. Nat Rev Neurosci 2001;2:727–733.
   PubMed Web of Science ®Google Scholar
• Shi Y, Feng Y, Kang J, et al. Critical regulation of CD4+ T cell survival and autoimmunity by beta-arrestin 1. Nat Immunol 2007;8:817–824.
   PubMed Web of Science ®Google Scholar
• Li J, Wei B, Guo A, et al. Deficiency of β-arrestin 1 ameliorates collagen-induced arthritis with impaired TH17 cell differentiation. Proc Natl Acad Sci USA 2013;110:7395–7400.
   PubMed Web of Science ®Google Scholar
• Wang G, Liu Y, Yang M, et al. Effects of beta-arrestin 2 on cytokine production of CD4+ T lymphocytes of mice with allergic asthma. Indian J Exp Biol 2011;49:585–593.
   PubMed Web of Science ®Google Scholar